Enterprise AI × Finance
Estimated watch time
12 minutes
Tom Gamblin
Director of product innovation
The time is now
Generative AI will transform patient engagement, medical research, and clinician experience, and healthcare and life science (HCLS) business, technology and clinical leaders are scrambling to understand, govern, and plan a strategic response to the new capabilities and risks. HCLS leaders especially must address two critical challenges when implementing AI – privacy and security, and workforce management.
Join this interactive webinar as Evident experts explore how generative AI can bring long-term transformative impact to your digital product suite and shed light on the crucial steps that business, clinical, and technology leaders must take to position their organisations for success.
Insight Agenda
Using large datasets and machine learning, healthcare organizations can find insights faster and more accurately with AI, enabling improved satisfaction both internally and with those they serve.
Using large datasets and machine learning, healthcare organizations can find insights faster and more accurately with AI, enabling improved satisfaction both internally and with those they serve.
Using large datasets and machine learning, healthcare organizations can find insights faster and more accurately with AI, enabling improved satisfaction both internally and with those they serve.
Highlights
Generative AI has quickly become a major factor in health care, but executives must understand how to use the technology in order to capitalize on its potential while avoiding the risks inherent in applying it to patient care. We analyzed generative AI use cases across different health segments, looking at both solutions already on the market and those likely to arrive soon.
Emerging generative AI use cases now exist in all health care segments, from providers and pharmaceutical firms to payers, medtech, service providers, and public health agencies.
Companies need to manage the potential risks of AI, including biased outputs, false results, abuse of patient privacy, and over reliance among patients on AI-generated guidance.
To create the right foundation for generative AI, health care organisations should create an enterprise-wide strategy, build data systems, invest in capabilities, forge strategic partnerships, and integrate with the broader industry ecosystem.
Generative AI is accelerating drug discovery, improving clinical-trial planning and execution, and leading to more precision medicine therapies.
A rapid and risk-managed process for new product validation and development
Bringing existing technology up to market-leading standards
Crafting the ultimate digital product suite that transforms digitally ambitious organisations